Fig. 4From: Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitroα-SMA and FN protein expression in HepG2 treated with EVE. Western blot analysis was performed to evaluate a) α-SMA and b) FN expression in HepG2 cells treated or untreated with EVE (10 or 100 nM) for 24 h. GAPDH was included as loading control. Representative blot of three independent experimentsBack to article page